A phase III, open-label, uncontrolled, multicentre, rollover study to assess safety and efficacy of LB03002 administered weekly in adults with growth hormone deficiency.
- Conditions
- Growth hormone deficiency in adultsMedDRA version: 8.1Level: LLTClassification code 10056438Term: Growth hormone deficiency
- Registration Number
- EUCTR2006-002278-24-CZ
- Lead Sponsor
- BioPartners GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 150
1) Patients (male and female) who have completed the Visit 8 of preceding main study (BPLG-005) and are willing to continue their participation in an extension study.
2) If female, women of child-bearing potential who are using a reliable method of contraception and be willing to use it throughout the study. A negative urine pregnancy test at Visit 0 is required for females of child-bearing potential.
3) Written informed consent of the patient.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
1) Evidence of active malignancy or growth of a previously stable tumor.
2) Benign intracranial hypertension.
3) Evidence of growth of pituitary adenoma or other intracranial tumor within the last 12 months, or patients without MRI or CT data to confirm the tumor stability within the last 12 months. (footnote: An additional MRI or CT scan will be conducted to confirm the tumor stability if a patient meets other inclusion and exclusion criteria, but DOES NOT have MRI or CT date within last 12 months to confirm th etumor stbility.)
4) Non-compliance with medications, un-cooperativeness or drug abuse during the BPLG-005 study.
5) Patients who are not able to comply with the study protocol for any reason.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.